Literature DB >> 20610154

Adiposity is increased among high-functioning, non-ambulatory patients with spinal muscular atrophy.

Douglas M Sproule1, Jacqueline Montes, Sally Dunaway, Megan Montgomery, Vanessa Battista, Dorcas Koenigsberger, Bill Martens, Wei Shen, Mark Punyanitya, Maryjane Benton, Hailly Butler, Jayson Caracciolo, Eugenio Mercuri, Richard Finkel, Basil Darras, Darryl C De Vivo, Petra Kaufmann.   

Abstract

The relationship between body composition and function in spinal muscular atrophy (SMA) is poorly understood. 53 subjects with SMA were stratified by type and Hammersmith functional motor scale, expanded score into three cohorts: low-functioning non-ambulatory (type 2 with Hammersmith score < 12, n=19), high-functioning non-ambulatory (type 2 with Hammersmith score > or = 12 or non-ambulatory type 3, n=17), and Ambulatory (n=17). Lean and fat mass was estimated using dual-energy X-ray absorptiometry. Anthropometric data was incorporated to measure fat-free (lean mass in kg/stature in m(2)) and fat (fat mass in kg/stature in m(2)) mass indices, the latter compared to published age and sex norms. Feeding dysfunction among type 2 subjects was assessed by questionnaire. Fat mass index was increased in the high-functioning non-ambulatory cohort (10.4+/-4.5) compared with both the ambulatory (7.2+/-2.1, P=0.013) and low-functioning non-ambulatory (7.6+/-3.1, P=0.040) cohorts. 12 of 17 subjects (71%) in the high-functioning non-ambulatory cohort had fat mass index > 85th percentile for age and gender (connoting "at risk of overweight") versus 9 of 19 subjects (47%) in the low-functioning non-ambulatory cohort and 8 of 17 ambulatory subjects (47%). Despite differences in clinical function, a similar proportion of low functioning (7/18, 39%) and high functioning (2/7, 29%) type 2 subjects reported swallowing or feeding dysfunction. Non-ambulatory patients with relatively high clinical function may be at particular risk of excess adiposity, perhaps reflecting access to excess calories despite relative immobility, emphasizing the importance of individualized nutritional management in SMA. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20610154      PMCID: PMC2902766          DOI: 10.1016/j.nmd.2010.05.013

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  31 in total

1.  Relation of BMI to fat and fat-free mass among children and adolescents.

Authors:  D S Freedman; J Wang; L M Maynard; J C Thornton; Z Mei; R N Pierson; W H Dietz; M Horlick
Journal:  Int J Obes (Lond)       Date:  2005-01       Impact factor: 5.095

2.  Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition.

Authors:  R B Mazess; H S Barden; J P Bisek; J Hanson
Journal:  Am J Clin Nutr       Date:  1990-06       Impact factor: 7.045

3.  Body composition determined with MR in patients with Duchenne muscular dystrophy, spinal muscular atrophy, and normal subjects.

Authors:  A Leroy-Willig; T N Willig; M C Henry-Feugeas; V Frouin; E Marinier; A Boulier; F Barzic; E Schouman-Claeys; A Syrota
Journal:  Magn Reson Imaging       Date:  1997       Impact factor: 2.546

4.  Feeding problems and weight gain in Duchenne muscular dystrophy.

Authors:  Marika Pane; Isabella Vasta; Sonia Messina; Domenica Sorleti; Annie Aloysius; Federico Sciarra; Fortunato Mangiola; Maria Kinali; Enzo Ricci; Eugenio Mercuri
Journal:  Eur J Paediatr Neurol       Date:  2006-10-10       Impact factor: 3.140

5.  Performance of dual-energy x-ray absorptiometry in evaluating bone, lean body mass, and fat in pediatric subjects.

Authors:  G M Chan
Journal:  J Bone Miner Res       Date:  1992-04       Impact factor: 6.741

6.  Pilot trial of phenylbutyrate in spinal muscular atrophy.

Authors:  Eugenio Mercuri; Enrico Bertini; Sonia Messina; Marco Pelliccioni; Adele D'Amico; Francesca Colitto; Massimiliano Mirabella; Francesco D Tiziano; Tiziana Vitali; Carla Angelozzi; Maria Kinali; Marion Main; Christina Brahe
Journal:  Neuromuscul Disord       Date:  2004-02       Impact factor: 4.296

7.  Increased fat mass and high incidence of overweight despite low body mass index in patients with spinal muscular atrophy.

Authors:  Douglas M Sproule; Jacqueline Montes; Megan Montgomery; Vanessa Battista; Dorcas Koenigsberger; Wei Shen; Mark Punyanitya; Darryl C De Vivo; Petra Kaufmann
Journal:  Neuromuscul Disord       Date:  2009-05-07       Impact factor: 4.296

8.  Nutritional assessment in Duchenne muscular dystrophy.

Authors:  T N Willig; L Carlier; M Legrand; H Rivière; J Navarro
Journal:  Dev Med Child Neurol       Date:  1993-12       Impact factor: 5.449

9.  Reliability of the Hammersmith functional motor scale for spinal muscular atrophy in a multicentric study.

Authors:  E Mercuri; S Messina; R Battini; A Berardinelli; P Boffi; R Bono; C Bruno; N Carboni; C Cini; F Colitto; A D'Amico; C Minetti; M Mirabella; T Mongini; L Morandi; N Dlamini; S Orcesi; M Pelliccioni; M Pane; A Pini; A V Swan; M Villanova; G Vita; M Main; F Muntoni; E Bertini
Journal:  Neuromuscul Disord       Date:  2006-01-20       Impact factor: 4.296

10.  Reproducibility of pediatric whole body bone and body composition measures by dual-energy X-ray absorptiometry using the GE Lunar Prodigy.

Authors:  Lauren Margulies; Mary Horlick; John C Thornton; Jack Wang; Elli Ioannidou; Steven B Heymsfield
Journal:  J Clin Densitom       Date:  2005       Impact factor: 2.963

View more
  12 in total

Review 1.  Spinal Muscular Atrophy.

Authors:  Stephen J Kolb; John T Kissel
Journal:  Neurol Clin       Date:  2015-11       Impact factor: 3.806

2.  Association Between Body Mass Index and Disability in Children With Charcot-Marie-Tooth Disease.

Authors:  Gabrielle A Donlevy; Sarah P Garnett; Kayla M D Cornett; Marnee J McKay; Jennifer N Baldwin; Rosemary R Shy; Sabrina W Yum; Timothy Estilow; Isabella Moroni; Maria Foscan; Emanuela Pagliano; Davide Pareyson; Matilde Laura; Trupti Bhandari; Francesco Muntoni; Mary M Reilly; Richard S Finkel; Janet E Sowden; Katy J Eichinger; David N Herrmann; Michael E Shy; Joshua Burns; Manoj P Menezes
Journal:  Neurology       Date:  2021-09-07       Impact factor: 9.910

3.  SMA valiant trial: a prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy.

Authors:  John T Kissel; Bakri Elsheikh; Wendy M King; Miriam Freimer; Charles B Scott; Stephen J Kolb; Sandra P Reyna; Thomas O Crawford; Louise R Simard; Kristin J Krosschell; Gyula Acsadi; Mary K Schroth; Guy D'Anjou; Bernard LaSalle; Thomas W Prior; Susan Sorenson; Jo Anne Maczulski; Kathryn J Swoboda
Journal:  Muscle Nerve       Date:  2014-02       Impact factor: 3.217

4.  Neurodegeneration in spinal muscular atrophy: from disease phenotype and animal models to therapeutic strategies and beyond.

Authors:  Umrao R Monani; Darryl C De Vivo
Journal:  Future Neurol       Date:  2014-01-01

5.  SMA CARNIVAL TRIAL PART II: a prospective, single-armed trial of L-carnitine and valproic acid in ambulatory children with spinal muscular atrophy.

Authors:  John T Kissel; Charles B Scott; Sandra P Reyna; Thomas O Crawford; Louise R Simard; Kristin J Krosschell; Gyula Acsadi; Bakri Elsheik; Mary K Schroth; Guy D'Anjou; Bernard LaSalle; Thomas W Prior; Susan Sorenson; Jo Anne Maczulski; Mark B Bromberg; Gary M Chan; Kathryn J Swoboda
Journal:  PLoS One       Date:  2011-07-06       Impact factor: 3.240

Review 6.  Proximal spinal muscular atrophy: current orthopedic perspective.

Authors:  Gerrit Haaker; Albert Fujak
Journal:  Appl Clin Genet       Date:  2013-11-14

7.  Spinal Muscular Atrophy, types I and II: What are the differences in body composition and resting energy expenditure?

Authors:  Simona Bertoli; Ramona De Amicis; Chiara Mastella; Giulia Pieri; Ester Giaquinto; Alberto Battezzati; Alessandro Leone; Giovanni Baranello
Journal:  Clin Nutr       Date:  2016-11-16       Impact factor: 7.324

8.  Health, wellbeing and lived experiences of adults with SMA: a scoping systematic review.

Authors:  Hamish W Y Wan; Kate A Carey; Arlene D'Silva; Steve Vucic; Matthew C Kiernan; Nadine A Kasparian; Michelle A Farrar
Journal:  Orphanet J Rare Dis       Date:  2020-03-12       Impact factor: 4.123

9.  SMA-MAP: a plasma protein panel for spinal muscular atrophy.

Authors:  Dione T Kobayashi; Jing Shi; Laurie Stephen; Karri L Ballard; Ruth Dewey; James Mapes; Brett Chung; Kathleen McCarthy; Kathryn J Swoboda; Thomas O Crawford; Rebecca Li; Thomas Plasterer; Cynthia Joyce; Wendy K Chung; Petra Kaufmann; Basil T Darras; Richard S Finkel; Douglas M Sproule; William B Martens; Michael P McDermott; Darryl C De Vivo; Michael G Walker; Karen S Chen
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

10.  Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials.

Authors:  Eugenio Mercuri; Richard Finkel; Jacqueline Montes; Elena S Mazzone; Maria Pia Sormani; Marion Main; Danielle Ramsey; Anna Mayhew; Allan M Glanzman; Sally Dunaway; Rachel Salazar; Amy Pasternak; Janet Quigley; Marika Pane; Maria Carmela Pera; Mariacristina Scoto; Sonia Messina; Maria Sframeli; Gian Luca Vita; Adele D'Amico; Marleen van den Hauwe; Serena Sivo; Nathalie Goemans; Petra Kaufmann; Basil T Darras; Enrico Bertini; Francesco Muntoni; Darryl C De Vivo
Journal:  Neuromuscul Disord       Date:  2015-12-03       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.